D-001-2013 Class III Terminated
FDA drug recall D-001-2013 was initiated by McKesson Packaging Services on Mar 29, 2012 and is designated Class III. Reason for recall: Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point. The recall status is terminated (terminated Apr 11, 2013). Affected quantity: 187 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 10, 2012
- Initiation Date
- Mar 29, 2012
- Termination Date
- Apr 11, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 187 cartons
Product description
buPROPion Hydrochloride Extended-Release Tablets (XL), 150 mg, UD 100 Tablets (10 x 10) per carton, Rx only, Mfg By: CMIC-VPS Corporation, Cranbury, New Jersey 08512; blister barcode N (01)003 63739 449 10 7, Dist By: McKesson Packaging, Concord, NC 28027; NDC 63739-449-10, carton barcode 6373944910.
Reason for recall
Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.
Distribution pattern
Nationwide
Code information
Lot #: 0074583, Exp. Date 03/12
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-001-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026